Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
05/2012
05/15/2012CA2516993C Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/15/2012CA2501188C Combinatorial protein library screening by periplasmic expression
05/15/2012CA2409286C Dog & cat food compositions having a probiotic lactobacillus strain
05/09/2012EP2213292B1 Double-stranded oligonucleotides
05/09/2012EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
05/08/2012US8173396 Methods for reducing gluconoylation of proteins
05/08/2012US8173393 Expanding the eukaryotic genetic code
05/08/2012CA2520636C Variant humicola grisea cbh1.1
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012US20120108804 Compositions and methods for preparing short rna molecules and other nucleic acids
05/03/2012US20120107897 Double-stranded oligonucleotides
05/03/2012US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use
05/03/2012US20120107283 Human skin equivalents expressing exogenous polypeptides
05/02/2012EP1702064B1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
05/01/2012US8168432 Cell culture methods and devices utilizing gas permeable materials
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168168 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
05/01/2012CA2400559C Humanized antibodies that sequester .alpha..beta. peptide
04/2012
04/26/2012US20120100570 Site-Specific Incorporation of Redox Active Amino Acids into Proteins
04/26/2012US20120100535 Methods for quantitative determination of methylation density in a dna locus
04/25/2012EP1601767B1 USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
04/25/2012CN1842589B Systems and methods for separating and concentrating regenerative cells from tissue
04/25/2012CN101069744B 流感疫苗组合物 Influenza vaccine composition
04/24/2012US8163875 Polymer conjugated glycosylated neublastin
04/24/2012US8163726 Administering to the mammal with the angiogenesis-mediated disease or condition an amount effective to inhibit, reduce, or prevent angiogenesis of an immunophilin binding active agent, e.g., rapamycin, a rapamycin analog, or tacrolimus ; diabetic retinopathy, macular degeneration
04/24/2012US8163485 Differential enzymatic fragmentation
04/19/2012US20120096586 Markerless transformation
04/18/2012EP1597351B1 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES
04/18/2012CN1418225B Monoclonal antibodies to the human ldl receptor, their production and use
04/17/2012US8158427 Cell culture methods and devices utilizing gas permeable materials
04/17/2012US8158426 Cell culture methods and devices utilizing gas permeable materials
04/12/2012US20120087938 Consensus/ancestral immunogens
04/11/2012EP1682677B1 Differential enzymatic fragmentation
04/11/2012CN101374948B Variant humicola grisea CBH1.1
04/10/2012US8153126 Anti-αvβ6 antibodies
04/10/2012CA2534349C Human skin equivalents expressing exogenous polypeptides
04/10/2012CA2523610C A forward mutation assay based on 5-fluorouracil resistance
04/10/2012CA2498191C Method of inhibiting choroidal neovascularization
04/03/2012US8148505 Method of α-selective glycosylation
04/03/2012US8148322 Method and carrier complexes for delivering molecules to cells
04/03/2012CA2287776C Regulation of quinolate phosphoribosyl transferase expression
03/2012
03/29/2012US20120077706 Method for assaying protein-protein interaction
03/28/2012CN1780920B Gene expression suppression agents
03/27/2012US8145436 Method and systems for identifying micro-RNA targets and synthesizing novel micro-RNAs and uses of the same
03/27/2012US8142998 Osteoarthritis biomarkers and uses thereof
03/27/2012CA2362964C Fucosyl transferase gene
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/21/2012EP1689887B1 Methods for quantitative determination of methylation density in a dna locus
03/21/2012EP1664321B1 Methods for expression and purification of immunotoxins
03/20/2012US8138312 Compositions for regulation of tumor necrosis factor-alpha
03/20/2012US8138309 Modified rubisco large subunit n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1,5-bisphosphate
03/20/2012US8138307 Parkin interacting polypeptides and methods of use
03/20/2012US8137948 Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
03/20/2012US8137696 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
03/14/2012EP1694622B1 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
03/14/2012EP1599586B9 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth
03/13/2012US8133862 Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
03/13/2012US8133709 Target sequences for synthetic molecules
03/13/2012CA2502358C Methods for purifying radiolabelled compounds
03/08/2012US20120059150 Methods for the production of apolipoproteins in transgenic plants
03/06/2012US8129167 UL16 binding protein 4
03/06/2012CA2504134C Process for concentration of macromolecules
03/06/2012CA2452474C Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
02/2012
02/29/2012EP1546399B1 Terminal phosphate blocked nucleoside polyphosphates
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124070 Probiotics for pet food applications
02/23/2012US20120046591 Treatment devices and methods with extending elements
02/23/2012US20120046586 Skin treatment devices and methods with pre-stressed configurations
02/23/2012US20120046446 p16 MEDIATED REGULATION OF NMDA RECEPTORS
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/21/2012US8119392 Tissue engineering; modifying cell surface using micropatterning; amplified polymer containing pyrrolidone units and (meth)acrylate units
02/21/2012CA2353698C Human hybrid host cell for mammalian gene expression
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/15/2012EP2418281A2 Methods and compositions for delivering polynucleotides
02/15/2012EP2418220A2 Interferon alpha antibodies and their uses
02/14/2012US8114654 Site-specific incorporation of redox active amino acids into proteins
02/14/2012US8114628 Expanding the eukaryotic genetic code
02/09/2012US20120035354 Materials and methods for the modification of plant lignin content
02/09/2012US20120034675 Tyrosinase mutant and methods of use thereof
02/09/2012US20120034616 Method for Modulating Epithelial Stem Cell Lineage
02/08/2012CN102344960A Quantification of gene expression
02/08/2012CN102344491A Interferon alpha antibodies and their uses
02/07/2012US8110726 Polynucleotides encoding cellulose synthase from pinus radiata and methods of use for regulating polysaccharides of a plant
02/07/2012US8110723 Transcription factors
02/07/2012US8110399 Isolating nestin-positive stem cells, expanding and translplanting into a patient to replace lost or damaged insulin secreting cells; differentiating pancreatic stem cells to obtain cells that produce insulin and other hormones
02/07/2012US8110366 Method for evaluating cell populations
02/07/2012CA2519009C Nucleotide sequences regulating gene expression and constructs and methods utilizing same
02/07/2012CA2394850C Methods of using randomized libraries of zinc finger proteins for the identification of gene function
02/02/2012US20120030781 Lrrk2 polynucleotides and transgenic animals
02/02/2012US20120029061 Rna sequence-specific mediators of rna interference
02/02/2012US20120028838 Quantification of Gene Expression
02/02/2012US20120028312 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
02/01/2012CN1894581B 检测蛋白-蛋白相互作用的方法 Detecting protein - protein interaction methods
01/2012
01/31/2012US8108150 Optimization of crossover points for directed evolution
01/31/2012US8105785 Mylks as modifiers of branching morphogenesis and methods of use
01/31/2012CA2544847C Methods and compositions for detection of segmented negative strand rna viruses
01/26/2012US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS
01/26/2012US20120021490 Glucanases, nucleic acids encoding them and methods for making and using them
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 100